This is a retrospective, single-center study of adult patients with newly diagnosed acute
myelogenous leukemia (AML), who received intensive induction timed sequential …

Objectives We sought to determine the occurrence, risk factors, effect of antifungal
prophylaxis, and outcomes of invasive fungal infections (IFIs) in patients with acute myeloid …

Invasive fungal infections (IFIs) is an important complication for acute myeloid leukemia
(AML) patients receiving induction chemotherapy. However, the epidemiological information …

This study investigated the epidemiology and risk factors associated with invasive fungal
infections (IFIs) during induction chemotherapy in a cohort of Taiwanese patients with newly …

Invasive fungal infection (IFI) is among the leading causes for morbidity, mortality, and
economic burden for patients with acute leukemia. In the past few decades, the incidence of …

Background Intensive chemotherapy with severe neutropenia is associated with invasive
fungal infections (IFIs) leading to high mortality rates. During leukaemia induction …

Few reports analyze the incidence and clinical outcome of invasive fungal disease (IFD) in
patients with newly diagnosed acute myeloid leukemia (AML) undergoing intensive …

Invasive fungal diseases (IFDs) represent an important cause of treatment failure in adults
with acute leukemia. Because of leukemia's heterogeneity, the risk for IFDs is highly …

This stud y examined the epidemiology, risk factors, management, and outcome of invasive
fungal infection (IFI) in patients receiving chemotherapy for hematological malignancy in …

Although primary antifungal prophylaxis (PAP) is routinely administered in patients with
acute myeloid leukemia (AML) during remission-induction and consolidation chemotherapy …